UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Annals of oncology, 2018-12, Vol.29 (12), p.2334-2340

2018

Volltextzugriff (PDF)

Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients

Annals of oncology, 2021-11, Vol.32 (11), p.1443-1444

2021

Volltextzugriff (PDF)

Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group

Annals of oncology, 2016-03, Vol.27 (3), p.397-408

2016

Volltextzugriff (PDF)

Reduced risk of second primary cancer in patients treated with immune checkpoint inhibitors for a first cancer

Annals of oncology, 2020-12, Vol.31 (12), p.1773-1775

2020

Volltextzugriff (PDF)

Checkpoint inhibition: protecting against or predisposing for second primary tumors? Reply to the Letter to the Editor ‘Checkpoint inhibition: protecting against or predisposing for second primary tumors?’ by K. P. M. Suijkerbuijk, A. M. May and M. J. M. van Eijs

Annals of oncology, 2021-08, Vol.32 (8), p.1055-1057

2021

Volltextzugriff (PDF)

Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors

Lung cancer (Amsterdam, Netherlands), 2023-08, Vol.182, p.107280-107280, Article 107280

2023

Volltextzugriff (PDF)

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Annals of oncology, 2018-02, Vol.29 (2), p.523-523

2018

Volltextzugriff (PDF)

Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol

Annals of oncology, 2017-11, Vol.28 (11), p.2773-2779

2017

Volltextzugriff (PDF)

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group

British journal of cancer, 2017-01, Vol.116 (3), p.303-309

2017

Volltextzugriff (PDF)

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Annals of oncology, 2015-07, Vol.26 (7), p.1353-1362

2015

Volltextzugriff (PDF)

Alienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse

Annals of oncology, 2018-10, Vol.29, p.viii333-viii333

2018

Volltextzugriff (PDF)

EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors

Annals of oncology, 2018-10, Vol.29, p.viii57-viii57

2018

Volltextzugriff (PDF)

EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors

Annals of oncology, 2018-03, Vol.29, p.iii13-iii13

2018

Volltextzugriff (PDF)

Physical activity and lifestyle in women with metastatic breast cancer: The ABLE study

Annals of oncology, 2018-10, Vol.29, p.viii116-viii116

2018

Volltextzugriff (PDF)

Proof-of-concept study evaluating a new tool for standardising radiological assessment of tumour response to treatment in routine clinical practice

Annals of oncology, 2018-10, Vol.29, p.viii482-viii482

2018

Volltextzugriff (PDF)

Ovarian suppression failure during GnRH agonist treatment: A report of three breast cancer patients

Journal of gynecology obstetrics and human reproduction, 2018-06, Vol.47 (6), p.261-264

2018

Volltextzugriff (PDF)

Data-mining of 110 172 electronic patient records with the ConSoRe tool: An analysis of second primary cancer in a comprehensive cancer center

Annals of oncology, 2018-10, Vol.29, p.viii482-viii482

2018

Volltextzugriff (PDF)

Actionable molecular alterations in advanced gynecologic malignancies: updated results from the ProfiLER program in France

Annals of oncology, 2017-10, Vol.28, p.vii14-vii14

2017

Volltextzugriff (PDF)

Multidisciplinary management of advanced ovarian cancer for an optimal therapeutic strategy

European journal of gynaecological oncology, 2017, Vol.38 (2), p.175-180

2017

Volltextzugriff (PDF)

SFSPM 2018 — Congrès de la Société Française de Sénologie et de Pathologie Mammaire (Avignon, 7-9/11-2018)

Oncologie (Paris, France), 2018-07, Vol.20 (7-12), p.145-189

2018

Volltextzugriff (PDF)

1058P Hyperprogressive disease during immune checkpoint inhibitor: A cloudy phenomenon with real consequences

Annals of oncology, 2024-09, Vol.35, p.S703-S704

2024

Volltextzugriff (PDF)

After-cancer phase: Between continuation and reinvention, which sequel?

Oncologie (Paris, France), 2016-04, Vol.18 (2-3), p.140-144

2016

Volltextzugriff (PDF)

1760MO Impact of immune checkpoint blockade therapy according to CD274 copy number alterations: A retrospective study in the ProfiLER cohort

Annals of oncology, 2021-09, Vol.32, p.S1211-S1211

2021

Volltextzugriff (PDF)

L’après-cancer : entre prolongement et réinvention, quelles suites… ?

Oncologie (Paris, France), 2016-04, Vol.18 (2-3), p.140-144

2016

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(83)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Oncology
(18)
Humans
(14)
Female
(11)
Life Sciences
(8)
Adult
(7)
Breast Cancer
(7)
Middle Aged
(7)
Aged
(5)
Breast Neoplasms - Pathology
(5)
Cancer
(5)
Prognosis
(5)
Chemotherapy
(4)
Male
(4)
Metastasis
(4)
Biomarkers, Tumor - Genetics
(3)
Breast Neoplasms - Drug Therapy
(3)
Cancer Therapies
(3)
Hematology, Oncology And Palliative Medicine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(50)
Oncologie
(6)
Esmo Open
(4)
Cancer Research
(3)
European Journal Of Cancer
(3)
Esmo Real World Data And Digital Oncology
(2)
Value In Health
(2)
Acta Orthopaedica Belgica
(1)
Blood
(1)
Breast Cancer
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients

Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group

Reduced risk of second primary cancer in patients treated with immune checkpoint inhibitors for a first cancer

Checkpoint inhibition: protecting against or predisposing for second primary tumors? Reply to the Letter to the Editor ‘Checkpoint inhibition: protecting against or predisposing for second primary tumors?’ by K. P. M. Suijkerbuijk, A. M. May and M. J. M. van Eijs

Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Alienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse

EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors

EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors

Physical activity and lifestyle in women with metastatic breast cancer: The ABLE study

Proof-of-concept study evaluating a new tool for standardising radiological assessment of tumour response to treatment in routine clinical practice

Ovarian suppression failure during GnRH agonist treatment: A report of three breast cancer patients

Data-mining of 110 172 electronic patient records with the ConSoRe tool: An analysis of second primary cancer in a comprehensive cancer center

Actionable molecular alterations in advanced gynecologic malignancies: updated results from the ProfiLER program in France

Multidisciplinary management of advanced ovarian cancer for an optimal therapeutic strategy

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial

SFSPM 2018 — Congrès de la Société Française de Sénologie et de Pathologie Mammaire (Avignon, 7-9/11-2018)

1058P Hyperprogressive disease during immune checkpoint inhibitor: A cloudy phenomenon with real consequences

After-cancer phase: Between continuation and reinvention, which sequel?

1760MO Impact of immune checkpoint blockade therapy according to CD274 copy number alterations: A retrospective study in the ProfiLER cohort

L’après-cancer : entre prolongement et réinvention, quelles suites… ?

Suchergebnisse filtern